Trial
NCT00430716
To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.
Phase IVTERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborators
—
Condition
Pulmonary Arterial Hypertension
Intervention
Sildenafil citrate
Why stopped
This study was terminated at the recommendation of an independent Data Monitoring Committee. The decision was not based on any safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-12-22